. As a result the 12% TCA soluble component is generally called glycomacropeptide (GMP). After elimination of TCA, this fraction (preparation 1) was used for several studies on biological activities in dogs and rats (Shlygin etal, 1971; Chernikov ef al, 1974; Stan et al, 1974; Vasilevskaya et al, 1977; Chernikov et al, 1979) . For some studies, a further fractionation was made on G-75 Sephadex (Stan et al, 1983) or G50 Sephadex . However, the fractions obtained and tested have never been characterized with accuracy as regards their glycosylation and phosphorylation levels or their genetic variants.
An industrial preparation (preparation 2) was used to study gastric secretions in the calf (Legeas, 1983; Guilloteau et al, 1986 Guilloteau et al, , 1994 . The Recently, in order to study pancreatic secretions in the pig, Beucher (1993) and Beucher etal (1994) In the following review, we have chosen to exclude observations made using whole casein or whole casein hydrolysates; the effects observed after intravenous injection of these products, especially vomiting and the inhibitory effects of the digestive myoelectrical activity (Vasilevskaya and Klimashima, 1979; Stan et al, 1983) seem to result from other peptides with an opiate activity (Stan et al, 1983 Stan and Ekimovsky, 1987 (Shlygin et al, 1971; Chernikov et al, 1974; Vasilevskaya et al, 1977) . On the contrary, it stimulates the secretion of gastric proteinases in dogs with a Heidenein souch (Vasilevskaya et al, 1977) . In these experiments, GMP were briefly infused and the quantities used varied considerably from one study to another (from 0.1 to 3.3 mg/kg LW). The response time was relatively long (1-2 h following infusion) (fig 3) and the effects lasted from 3-5 h. The inhibitory effect on gastric acid secretion was reproduced in rats using an isolated fraction of GMP (Stan et al, 1983) . This effect could be in good agreement with the decrease in gastrin levels in the blood and in the antral tissue observed by Aleinik et al (1986) . In this case, however, the quantities used (33-55 mg/ kg LW) were higher than in dogs (particularly as it was a purified fraction) and the response time was only 30 min. Other studies were made in preruminant calves fitted with a gastric pouch (developed by Guilloteau and Lecalve, 1977) (Legeas, 1983; Guilloteau etal, 1986 , and unpublished results). (Legeas, 1983; Guilloteau et al, 1994, and (fig 4) (Beucher, 1993 (Beucher et al, 1994 
Identification of the active forms of CMP
The increase in pancreatic juice and proteins in the pig is not related to the protein mass of the fraction perfused into the intestinal lumen since administration of a 20-fold larger amount of CMP-free casein had no effect (Beucher, 1993) . Moreover, the pancreatic secretion responses observed after duodenal infusion of different digesta are correlated to their CMP content (Beucher, 1993) . In the calf the gastric secretion responses depend on the dietary proportion of CMP (Guilloteau et al, 1994) and the same applied to the man. CMP therefore appears to be responsible for the observed effects.
The nature of the CMP fraction seems to play a determining role. It can affect the response time. In the dog, for example, one fraction inhibits the acid secretion immediately after the intravenous infusion, whereas another fraction will have a response time ranging between 1.5 and 2 h . Two different fractions can have opposite effects on the acid secretion stimulated by pentagastrin (Stan et al, 1983 ).
However, the content of these fractions has neither been identified nor precisely characterized. By applying different hydrolysis treatments to GMP before intravenous injection (fig 5) , Chernikov ef al (1979) demonstrated that the whole CMP molecule is not necessary for peptide activity but that carbohydrate chains are essential. This was confirmed by Beucher et al (1994) who demonstrated that luminal infusion of the non-glycosylated fraction of the peptide into an isolated rat duodenojejunum had no effect on the release of CCK, unlike certain glycosylated forms.
The number of bound carbohydrate chains, their nature and binding site seem to be involved in the biological activity of the molecule (Beucher et al, 1994) . The fraction containing the slightly glycosylated forms of the A variant of CMP, when perfused alone in the rat duodenojejunum, highly stimulated the release of CCK. Most glycosylated forms were inactive. The B variant of CMP (which differs from the A variant only in 2 amino-acid residues) with a glycosylation level equivalent to the active fraction had no effect. Finally the presence of sialic acid at the extremity of the carbohydrate chains seems to be essential to CMP activity, since the removal of this residue eliminated the activity. However, the results obtained by Chernikov et al (1979) the humoral system of the organism Beucher et al, 1994) .
Contrary to the hypotheses made by Chernikov ef al (1979) and Aleinik et al (1986) , it may not be necessary for the peptide or some active fragments to enter the blood to inhibit gastric secretion (Beucher et al, 1994) . The rapidity of the response at the very beginning of the CMP infusion in the lumen of the rat intestinal loop suggests that the peptide absorption is probably unnecessary and that the stimulus is triggered on the mucous side of the intestinal cell. These hypotheses are supported by a much longer response time (30 min) when the peptide is in contact with the serous membrane of an isolated stomach . Moreover, the doses responsible for the effect in the intestinal loop (50 pg/ml, mucous side) are about 10 times lower than used in the stomach (400 pg/ml, serous side (Guilloteau ef al, 1994 (Reiter, 1978) . GMP 
